Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study
This real-world study demonstrated that ustekinumab has sustained efficacy in the treatment of ulcerative colitis in a real-world setting.
Authors
- Daniel Wirth (ORCID: https://orcid.org/0000-0002-3302-3001)
- Clas-Göran af Björkesten (ORCID: https://orcid.org/0000-0003-3406-8612)
- Hans Henricson
- Taru Hallinen
- Jyrki Tillonen
- Taina Sipponen (ORCID: https://orcid.org/0000-0002-8069-5273)
- Ilkka Vihriälä
- Mikko Kellokumpu
- Heli Eronen (ORCID: https://orcid.org/0000-0003-1504-5642)
- Mervi Kuronen
- Ritva Koskela (ORCID: https://orcid.org/0000-0003-3404-0089)
- Milla‐Maria Tauriainen (ORCID: https://orcid.org/0000-0002-0176-6409)
- Heikki Nuutinen
- Erkki Soini (ORCID: https://orcid.org/0000-0003-4259-7610)
- Pauliina Molander (ORCID: https://orcid.org/0000-0002-9494-3573)
- Aki Juhani Käräjämäki (ORCID: https://orcid.org/0000-0002-9235-6762)
- Minni Koivunen
- Minna Oksanen
- Ulla-Maija Suhonen
Institutions
- University of Helsinki (FI)
- Oulu University Hospital (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Kajaani University of Applied Sciences (FI)
- Kuopio University Hospital (FI)
- Lapland Central Hospital (FI)
- Vaasa Central Hospital (FI)
- Kanta-Hämeen Keskussairaala (FI)
- ESiOR Oy (Finland) (FI)
- Janssen (Germany) (DE)
- Päijät-Hämeen Keskussairaala (FI)
- Central Finland Health Care District (FI)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1097/meg.0000000000002939
- Citations
- 3
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- Cilag